Wuhan, China

Bin Xing

This inventor holds 1 USPTO granted patent. Top assignee: Wuhan United Imaging Life Science Instrument Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bin Xing. Retrieved from https://idiyas.com/inventor/bin-xing-gc5csgh5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bin Xing and MRI Gradient Sensitivity Correction.

Introduction

Bin Xing is an inventor associated with Wuhan, China, and Wuhan United Imaging Life Science Instrument Co., Ltd. His patent work addresses gradient sensitivity correction in magnetic resonance imaging (MRI).

Latest Patents

The available information lists one patent for Xing: “Methods and Systems for Gradient Sensitivity Correction.” The disclosed method obtains a three-dimensional image of a phantom using an MRI device, determines the phantom’s fitted size along a target axis, and uses that measurement alongside its known actual size to correct the device’s gradient sensitivity. The record lists 1 patent for Xing.

Career Highlights

Xing’s listed invention focuses on using a phantom’s known dimensions to assess and correct MRI gradient sensitivity. This approach is intended to support more accurate imaging measurements.

Collaborations

Xing’s listed coworkers include Jianfan Zhou and Hongxia Lei. His patent is associated with Wuhan United Imaging Life Science Instrument Co., Ltd.

Conclusion

Bin Xing’s listed patent presents a phantom-based method for correcting MRI gradient sensitivity, reflecting his work in medical imaging technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…